 Ankush Gosain
Concepts (642)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hirschsprung Disease | 16 | 2023 | 90 | 7.470 |
Why?
| | Enterocolitis | 10 | 2023 | 33 | 5.170 |
Why?
| | Surgeons | 16 | 2023 | 236 | 3.800 |
Why?
| | Specialties, Surgical | 5 | 2021 | 67 | 3.080 |
Why?
| | Wounds and Injuries | 9 | 2023 | 674 | 2.420 |
Why?
| | Neural Crest | 6 | 2020 | 117 | 2.410 |
Why?
| | Biomedical Research | 9 | 2021 | 582 | 2.330 |
Why?
| | Enteric Nervous System | 7 | 2020 | 26 | 2.120 |
Why?
| | Pediatrics | 7 | 2021 | 982 | 2.080 |
Why?
| | General Surgery | 4 | 2021 | 125 | 1.940 |
Why?
| | Financing, Organized | 4 | 2021 | 33 | 1.820 |
Why?
| | Trauma Centers | 7 | 2023 | 347 | 1.690 |
Why?
| | National Institutes of Health (U.S.) | 3 | 2021 | 105 | 1.600 |
Why?
| | Receptor, Endothelin B | 5 | 2020 | 51 | 1.540 |
Why?
| | Intestines | 5 | 2021 | 325 | 1.500 |
Why?
| | Awards and Prizes | 2 | 2021 | 56 | 1.370 |
Why?
| | Bibliometrics | 2 | 2019 | 43 | 1.210 |
Why?
| | Near Drowning | 2 | 2017 | 4 | 1.130 |
Why?
| | Child | 48 | 2023 | 18401 | 1.110 |
Why?
| | Humans | 122 | 2023 | 114045 | 1.100 |
Why?
| | Surgical Procedures, Operative | 3 | 2018 | 206 | 1.080 |
Why?
| | Anorectal Malformations | 2 | 2018 | 102 | 1.060 |
Why?
| | Periodicals as Topic | 2 | 2019 | 180 | 1.050 |
Why?
| | Triage | 2 | 2020 | 197 | 1.050 |
Why?
| | Dysbiosis | 3 | 2023 | 145 | 1.000 |
Why?
| | Retrospective Studies | 31 | 2023 | 12521 | 0.940 |
Why?
| | Gastrostomy | 2 | 2022 | 89 | 0.900 |
Why?
| | Infant | 27 | 2023 | 7943 | 0.900 |
Why?
| | Waardenburg Syndrome | 1 | 2023 | 2 | 0.890 |
Why?
| | Intestinal Mucosa | 4 | 2015 | 532 | 0.870 |
Why?
| | Research Personnel | 3 | 2021 | 147 | 0.850 |
Why?
| | Wound Healing | 6 | 2008 | 254 | 0.800 |
Why?
| | Norepinephrine | 3 | 2008 | 201 | 0.800 |
Why?
| | Intellectual Disability | 1 | 2023 | 127 | 0.790 |
Why?
| | Mentors | 2 | 2021 | 155 | 0.790 |
Why?
| | Spleen | 4 | 2019 | 485 | 0.790 |
Why?
| | Down Syndrome | 2 | 2023 | 335 | 0.770 |
Why?
| | Fellowships and Scholarships | 2 | 2021 | 224 | 0.770 |
Why?
| | Analgesics, Non-Narcotic | 1 | 2023 | 117 | 0.760 |
Why?
| | Journal Impact Factor | 2 | 2019 | 27 | 0.760 |
Why?
| | Mycobiome | 1 | 2021 | 6 | 0.750 |
Why?
| | Botulinum Toxins | 1 | 2021 | 39 | 0.740 |
Why?
| | Comprehension | 2 | 2023 | 151 | 0.740 |
Why?
| | Wounds, Nonpenetrating | 4 | 2019 | 249 | 0.730 |
Why?
| | United States | 17 | 2023 | 12137 | 0.730 |
Why?
| | Choline O-Acetyltransferase | 2 | 2018 | 23 | 0.730 |
Why?
| | Education, Medical, Graduate | 3 | 2021 | 366 | 0.720 |
Why?
| | Health Literacy | 1 | 2023 | 160 | 0.720 |
Why?
| | Drowning | 2 | 2017 | 6 | 0.710 |
Why?
| | Receptors, Laminin | 1 | 2020 | 2 | 0.710 |
Why?
| | Appendicitis | 4 | 2022 | 112 | 0.700 |
Why?
| | Workload | 1 | 2021 | 131 | 0.700 |
Why?
| | Margins of Excision | 1 | 2020 | 29 | 0.700 |
Why?
| | Social Media | 2 | 2021 | 131 | 0.700 |
Why?
| | Thyroidectomy | 2 | 2020 | 62 | 0.690 |
Why?
| | Videoconferencing | 1 | 2020 | 57 | 0.690 |
Why?
| | Organizational Innovation | 1 | 2021 | 132 | 0.690 |
Why?
| | Gastroesophageal Reflux | 1 | 2022 | 229 | 0.690 |
Why?
| | Research Support as Topic | 1 | 2021 | 107 | 0.680 |
Why?
| | Cell Movement | 3 | 2020 | 863 | 0.680 |
Why?
| | Colorectal Neoplasms | 2 | 2023 | 592 | 0.680 |
Why?
| | Female | 56 | 2023 | 59324 | 0.670 |
Why?
| | Personnel Selection | 1 | 2020 | 62 | 0.670 |
Why?
| | Parenteral Nutrition | 3 | 2020 | 96 | 0.650 |
Why?
| | Immunoglobulin A, Secretory | 1 | 2019 | 9 | 0.650 |
Why?
| | Male | 52 | 2023 | 55396 | 0.640 |
Why?
| | Infant, Newborn | 15 | 2023 | 5038 | 0.630 |
Why?
| | Multimedia | 1 | 2018 | 10 | 0.620 |
Why?
| | Enterostomy | 1 | 2018 | 7 | 0.620 |
Why?
| | Sequence Deletion | 1 | 2019 | 166 | 0.620 |
Why?
| | Societies, Medical | 2 | 2021 | 655 | 0.610 |
Why?
| | Colon | 3 | 2020 | 232 | 0.610 |
Why?
| | Interviews as Topic | 1 | 2020 | 575 | 0.600 |
Why?
| | Wounds, Gunshot | 2 | 2021 | 193 | 0.600 |
Why?
| | Mice | 21 | 2023 | 14843 | 0.590 |
Why?
| | Animals | 31 | 2023 | 31565 | 0.580 |
Why?
| | Cloaca | 1 | 2018 | 47 | 0.580 |
Why?
| | Hematopoiesis, Extramedullary | 1 | 2017 | 5 | 0.580 |
Why?
| | Informed Consent | 1 | 2018 | 158 | 0.570 |
Why?
| | Efficiency | 1 | 2018 | 84 | 0.570 |
Why?
| | Parathyroidectomy | 2 | 2014 | 7 | 0.570 |
Why?
| | Hyperparathyroidism | 2 | 2014 | 12 | 0.570 |
Why?
| | Infant, Premature, Diseases | 1 | 2018 | 88 | 0.560 |
Why?
| | Parental Consent | 1 | 2017 | 22 | 0.550 |
Why?
| | Outpatients | 1 | 2020 | 325 | 0.550 |
Why?
| | Gastrointestinal Tract | 2 | 2018 | 169 | 0.550 |
Why?
| | Incidence | 8 | 2023 | 2314 | 0.540 |
Why?
| | B-Lymphocytes | 2 | 2019 | 762 | 0.540 |
Why?
| | Faculty, Medical | 2 | 2020 | 226 | 0.530 |
Why?
| | Publishing | 1 | 2018 | 123 | 0.530 |
Why?
| | Abdominal Injuries | 4 | 2019 | 107 | 0.530 |
Why?
| | Bone Transplantation | 6 | 2001 | 97 | 0.520 |
Why?
| | Health Services Misuse | 1 | 2016 | 36 | 0.520 |
Why?
| | Immunity, Cellular | 2 | 2015 | 247 | 0.520 |
Why?
| | Health Status Disparities | 1 | 2018 | 200 | 0.510 |
Why?
| | Firearms | 1 | 2021 | 300 | 0.510 |
Why?
| | Writing | 3 | 2021 | 82 | 0.500 |
Why?
| | Astrocytes | 1 | 2017 | 159 | 0.500 |
Why?
| | Disease Management | 2 | 2016 | 556 | 0.490 |
Why?
| | Appendectomy | 5 | 2022 | 66 | 0.490 |
Why?
| | Sarcoma | 1 | 2016 | 137 | 0.480 |
Why?
| | Internship and Residency | 2 | 2022 | 920 | 0.480 |
Why?
| | Staining and Labeling | 1 | 2015 | 134 | 0.470 |
Why?
| | Infant, Premature | 1 | 2018 | 478 | 0.470 |
Why?
| | Child, Preschool | 18 | 2023 | 9114 | 0.460 |
Why?
| | Child Development | 1 | 2018 | 384 | 0.450 |
Why?
| | Microbiota | 1 | 2021 | 648 | 0.450 |
Why?
| | Liver Neoplasms | 3 | 2023 | 504 | 0.440 |
Why?
| | Translocation, Genetic | 3 | 2017 | 92 | 0.440 |
Why?
| | Gene Deletion | 1 | 2015 | 356 | 0.440 |
Why?
| | Parents | 2 | 2018 | 1181 | 0.440 |
Why?
| | Vascular System Injuries | 1 | 2014 | 66 | 0.440 |
Why?
| | Emergency Medical Services | 1 | 2020 | 581 | 0.430 |
Why?
| | Metastasectomy | 2 | 2023 | 13 | 0.430 |
Why?
| | Gene Expression | 2 | 2017 | 1417 | 0.430 |
Why?
| | Pregnancy Complications | 3 | 2022 | 430 | 0.430 |
Why?
| | Severity of Illness Index | 1 | 2021 | 2537 | 0.430 |
Why?
| | Bombesin | 1 | 2013 | 12 | 0.430 |
Why?
| | Surgical Flaps | 9 | 2019 | 121 | 0.430 |
Why?
| | Tomography, X-Ray Computed | 7 | 2017 | 2272 | 0.420 |
Why?
| | Neurons | 2 | 2018 | 1277 | 0.420 |
Why?
| | Healthcare Disparities | 1 | 2018 | 479 | 0.410 |
Why?
| | Burns | 3 | 2005 | 237 | 0.410 |
Why?
| | Adolescent | 26 | 2023 | 17800 | 0.410 |
Why?
| | Lipoblastoma | 1 | 2012 | 1 | 0.400 |
Why?
| | Chromosomes, Human, Pair 8 | 1 | 2012 | 33 | 0.400 |
Why?
| | Anxiety | 1 | 2018 | 843 | 0.400 |
Why?
| | Osteogenesis, Distraction | 3 | 2001 | 11 | 0.400 |
Why?
| | Pandemics | 6 | 2022 | 1310 | 0.390 |
Why?
| | Patient Care Team | 1 | 2016 | 517 | 0.390 |
Why?
| | Aorta | 1 | 2014 | 388 | 0.380 |
Why?
| | Facial Bones | 3 | 2001 | 29 | 0.380 |
Why?
| | Laparoscopy | 3 | 2017 | 395 | 0.380 |
Why?
| | Physicians, Women | 2 | 2022 | 55 | 0.370 |
Why?
| | Disease Models, Animal | 6 | 2023 | 3498 | 0.370 |
Why?
| | Hepatoblastoma | 2 | 2023 | 27 | 0.360 |
Why?
| | Macaca mulatta | 3 | 2021 | 131 | 0.360 |
Why?
| | Omentum | 1 | 2010 | 8 | 0.360 |
Why?
| | Infarction | 1 | 2010 | 12 | 0.360 |
Why?
| | Endovascular Procedures | 1 | 2014 | 267 | 0.350 |
Why?
| | Referral and Consultation | 1 | 2015 | 632 | 0.350 |
Why?
| | Emergency Service, Hospital | 2 | 2020 | 1815 | 0.350 |
Why?
| | Cleft Palate | 4 | 1999 | 49 | 0.350 |
Why?
| | Mice, Knockout | 5 | 2020 | 2562 | 0.340 |
Why?
| | Anesthetics | 2 | 2021 | 54 | 0.330 |
Why?
| | Bacteria | 2 | 2021 | 725 | 0.330 |
Why?
| | Bone Remodeling | 3 | 1999 | 65 | 0.330 |
Why?
| | Parietal Bone | 2 | 2000 | 11 | 0.330 |
Why?
| | Phagocytosis | 2 | 2008 | 349 | 0.330 |
Why?
| | Transforming Growth Factor beta | 3 | 2001 | 445 | 0.330 |
Why?
| | Bone Plates | 3 | 1999 | 75 | 0.320 |
Why?
| | Zygoma | 3 | 1998 | 11 | 0.320 |
Why?
| | Venous Thromboembolism | 2 | 2023 | 230 | 0.310 |
Why?
| | Quality Improvement | 1 | 2016 | 944 | 0.310 |
Why?
| | Injury Severity Score | 4 | 2020 | 472 | 0.310 |
Why?
| | Digestive System Surgical Procedures | 2 | 2019 | 91 | 0.300 |
Why?
| | Postoperative Complications | 8 | 2021 | 2122 | 0.300 |
Why?
| | Adrenergic alpha-Agonists | 1 | 2007 | 29 | 0.290 |
Why?
| | Receptors, Adrenergic, alpha | 1 | 2007 | 28 | 0.290 |
Why?
| | Animal Feed | 2 | 2021 | 49 | 0.290 |
Why?
| | Mice, Transgenic | 4 | 2017 | 1947 | 0.280 |
Why?
| | Temporal Bone | 2 | 1997 | 44 | 0.280 |
Why?
| | Receptors, Adrenergic, beta | 1 | 2007 | 126 | 0.270 |
Why?
| | Angiogenesis Inducing Agents | 1 | 2006 | 21 | 0.270 |
Why?
| | Gastrointestinal Microbiome | 3 | 2021 | 502 | 0.260 |
Why?
| | Pancreas | 2 | 2019 | 276 | 0.260 |
Why?
| | Facial Nerve | 2 | 1997 | 30 | 0.260 |
Why?
| | Sympathomimetics | 1 | 2006 | 25 | 0.260 |
Why?
| | Acetylcholine | 2 | 2018 | 166 | 0.260 |
Why?
| | Gastrointestinal Motility | 2 | 2018 | 25 | 0.250 |
Why?
| | Treatment Outcome | 9 | 2020 | 9049 | 0.250 |
Why?
| | Acrocephalosyndactylia | 2 | 1996 | 10 | 0.250 |
Why?
| | Neurotransmitter Agents | 2 | 2018 | 75 | 0.250 |
Why?
| | Follow-Up Studies | 5 | 2018 | 4392 | 0.250 |
Why?
| | Neutrophils | 2 | 2018 | 1089 | 0.240 |
Why?
| | Digestive System | 1 | 2005 | 27 | 0.240 |
Why?
| | Reproductive Techniques, Assisted | 2 | 2022 | 32 | 0.240 |
Why?
| | Blood Vessels | 1 | 2006 | 179 | 0.240 |
Why?
| | Bacterial Translocation | 1 | 2005 | 35 | 0.240 |
Why?
| | Surveys and Questionnaires | 6 | 2022 | 4595 | 0.240 |
Why?
| | Surgical Wound Infection | 3 | 2015 | 246 | 0.230 |
Why?
| | Infertility, Female | 2 | 2022 | 93 | 0.230 |
Why?
| | Smiling | 2 | 2001 | 6 | 0.230 |
Why?
| | Skin Physiological Phenomena | 1 | 2004 | 26 | 0.230 |
Why?
| | Length of Stay | 4 | 2023 | 957 | 0.220 |
Why?
| | Parathyroid Glands | 2 | 2014 | 10 | 0.220 |
Why?
| | Practice Guidelines as Topic | 4 | 2019 | 1381 | 0.220 |
Why?
| | alpha-Defensins | 1 | 2023 | 11 | 0.220 |
Why?
| | Intestinal Neoplasms | 1 | 2023 | 24 | 0.220 |
Why?
| | Flatulence | 1 | 2023 | 2 | 0.220 |
Why?
| | Stomach Neoplasms | 1 | 2023 | 65 | 0.210 |
Why?
| | Cholestasis | 2 | 2023 | 225 | 0.210 |
Why?
| | Surgery, Plastic | 2 | 2001 | 24 | 0.210 |
Why?
| | Gastrointestinal Transit | 1 | 2022 | 6 | 0.210 |
Why?
| | Bone Substitutes | 2 | 2001 | 27 | 0.210 |
Why?
| | Up-Regulation | 3 | 2020 | 802 | 0.210 |
Why?
| | Anal Canal | 1 | 2023 | 83 | 0.210 |
Why?
| | Cytokines | 3 | 2023 | 1824 | 0.210 |
Why?
| | Hepatectomy | 2 | 2023 | 118 | 0.210 |
Why?
| | RNA, Ribosomal, 16S | 2 | 2023 | 485 | 0.210 |
Why?
| | Radiation Injuries | 2 | 2023 | 128 | 0.200 |
Why?
| | Endotoxemia | 1 | 2023 | 86 | 0.200 |
Why?
| | Neuroendocrine Tumors | 1 | 2023 | 85 | 0.200 |
Why?
| | Osteoblasts | 2 | 2000 | 106 | 0.200 |
Why?
| | Preoperative Care | 3 | 2018 | 319 | 0.200 |
Why?
| | Surrogate Mothers | 1 | 2022 | 2 | 0.200 |
Why?
| | Mice, Inbred C57BL | 5 | 2021 | 4680 | 0.200 |
Why?
| | Hernia, Inguinal | 1 | 2022 | 28 | 0.200 |
Why?
| | Facial Muscles | 3 | 2001 | 6 | 0.190 |
Why?
| | Adoption | 1 | 2022 | 38 | 0.190 |
Why?
| | Cleft Lip | 2 | 1999 | 31 | 0.190 |
Why?
| | Abortion, Spontaneous | 1 | 2022 | 89 | 0.190 |
Why?
| | Skin Neoplasms | 2 | 2001 | 754 | 0.190 |
Why?
| | Glucan Endo-1,3-beta-D-Glucosidase | 1 | 2021 | 2 | 0.190 |
Why?
| | Poisson Distribution | 1 | 2021 | 71 | 0.190 |
Why?
| | Proteobacteria | 1 | 2021 | 16 | 0.190 |
Why?
| | Resuscitation | 1 | 2023 | 221 | 0.190 |
Why?
| | Pain, Postoperative | 1 | 2023 | 190 | 0.190 |
Why?
| | Specialty Boards | 1 | 2021 | 32 | 0.190 |
Why?
| | Skin Transplantation | 2 | 2001 | 57 | 0.190 |
Why?
| | Fatty Liver | 1 | 2023 | 209 | 0.190 |
Why?
| | Young Adult | 6 | 2023 | 10444 | 0.190 |
Why?
| | Vascular Neoplasms | 1 | 2001 | 15 | 0.190 |
Why?
| | Accreditation | 1 | 2021 | 76 | 0.190 |
Why?
| | Nevus, Pigmented | 1 | 2001 | 34 | 0.190 |
Why?
| | Multienzyme Complexes | 1 | 2021 | 64 | 0.190 |
Why?
| | Osteogenesis | 2 | 2000 | 181 | 0.180 |
Why?
| | Craniotomy | 2 | 2000 | 68 | 0.180 |
Why?
| | Hemangioma | 1 | 2001 | 38 | 0.180 |
Why?
| | Aging | 2 | 2004 | 1611 | 0.180 |
Why?
| | Dissection | 3 | 2015 | 51 | 0.180 |
Why?
| | Anesthesia, General | 1 | 2021 | 44 | 0.180 |
Why?
| | Intussusception | 1 | 2020 | 28 | 0.180 |
Why?
| | Surgery Department, Hospital | 1 | 2020 | 22 | 0.180 |
Why?
| | Ulnar Nerve Compression Syndromes | 1 | 2000 | 4 | 0.180 |
Why?
| | Macrophages | 1 | 2007 | 1259 | 0.180 |
Why?
| | Peptide Hydrolases | 1 | 2021 | 103 | 0.180 |
Why?
| | Sexism | 1 | 2021 | 43 | 0.180 |
Why?
| | Intestine, Large | 1 | 2020 | 13 | 0.180 |
Why?
| | Craniofacial Abnormalities | 1 | 2001 | 59 | 0.180 |
Why?
| | Minority Groups | 1 | 2022 | 223 | 0.180 |
Why?
| | Depression, Postpartum | 1 | 2022 | 101 | 0.180 |
Why?
| | Milk | 1 | 2021 | 123 | 0.170 |
Why?
| | Risk Factors | 8 | 2023 | 8614 | 0.170 |
Why?
| | Acetaminophen | 1 | 2023 | 241 | 0.170 |
Why?
| | Herniorrhaphy | 2 | 2022 | 47 | 0.170 |
Why?
| | Pressure Ulcer | 1 | 2000 | 31 | 0.170 |
Why?
| | Laminin | 1 | 2020 | 69 | 0.170 |
Why?
| | Carpal Tunnel Syndrome | 1 | 2000 | 27 | 0.170 |
Why?
| | Hospitals, University | 1 | 2020 | 169 | 0.170 |
Why?
| | Fungi | 1 | 2021 | 124 | 0.170 |
Why?
| | Congresses as Topic | 1 | 2021 | 193 | 0.170 |
Why?
| | Maxillofacial Prosthesis | 1 | 1999 | 1 | 0.170 |
Why?
| | Organogenesis | 1 | 2020 | 55 | 0.170 |
Why?
| | Faculty | 1 | 2020 | 126 | 0.160 |
Why?
| | Pancreatic Pseudocyst | 1 | 2019 | 13 | 0.160 |
Why?
| | Adult | 17 | 2023 | 30375 | 0.160 |
Why?
| | Absorbable Implants | 1 | 1999 | 33 | 0.160 |
Why?
| | Pilonidal Sinus | 1 | 2019 | 2 | 0.160 |
Why?
| | Trisomy 18 Syndrome | 1 | 2019 | 2 | 0.160 |
Why?
| | Advisory Committees | 1 | 2020 | 207 | 0.160 |
Why?
| | Venous Thrombosis | 1 | 2021 | 141 | 0.160 |
Why?
| | Academies and Institutes | 1 | 2019 | 44 | 0.160 |
Why?
| | Reoperation | 3 | 2018 | 513 | 0.160 |
Why?
| | Random Allocation | 3 | 2014 | 328 | 0.160 |
Why?
| | Sepsis | 1 | 2005 | 507 | 0.160 |
Why?
| | Environment | 1 | 2021 | 333 | 0.160 |
Why?
| | Racism | 1 | 2021 | 99 | 0.160 |
Why?
| | Conservative Treatment | 1 | 2019 | 29 | 0.160 |
Why?
| | Abdominal Pain | 2 | 2010 | 134 | 0.160 |
Why?
| | Animals, Newborn | 1 | 2021 | 777 | 0.160 |
Why?
| | Inflammatory Bowel Diseases | 1 | 2023 | 284 | 0.160 |
Why?
| | Diagnosis, Differential | 3 | 2012 | 1331 | 0.160 |
Why?
| | Esophageal Atresia | 1 | 2019 | 23 | 0.160 |
Why?
| | Laparotomy | 2 | 2020 | 101 | 0.160 |
Why?
| | Science | 1 | 2019 | 48 | 0.160 |
Why?
| | Internet | 1 | 2023 | 591 | 0.160 |
Why?
| | Critical Illness | 1 | 2023 | 640 | 0.150 |
Why?
| | Drainage | 1 | 2019 | 145 | 0.150 |
Why?
| | Cerebral Cortex | 1 | 2001 | 380 | 0.150 |
Why?
| | Brain | 3 | 2021 | 2355 | 0.150 |
Why?
| | Vascular Surgical Procedures | 1 | 2001 | 260 | 0.150 |
Why?
| | Enbucrilate | 1 | 1998 | 1 | 0.150 |
Why?
| | Central Venous Catheters | 1 | 2018 | 40 | 0.150 |
Why?
| | Magnetic Resonance Imaging | 3 | 2012 | 3039 | 0.150 |
Why?
| | Fertility Preservation | 1 | 2018 | 46 | 0.150 |
Why?
| | Ovariectomy | 1 | 2018 | 116 | 0.150 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2020 | 186 | 0.150 |
Why?
| | Tissue Adhesives | 1 | 1998 | 16 | 0.150 |
Why?
| | Cephalometry | 2 | 1995 | 28 | 0.150 |
Why?
| | Cell Division | 1 | 2000 | 754 | 0.150 |
Why?
| | Catheter-Related Infections | 1 | 2018 | 61 | 0.150 |
Why?
| | Ovarian Cysts | 1 | 2017 | 8 | 0.150 |
Why?
| | Hydroxyapatites | 1 | 1997 | 12 | 0.150 |
Why?
| | Neutropenia | 1 | 2018 | 123 | 0.150 |
Why?
| | Ovarian Diseases | 1 | 2017 | 12 | 0.150 |
Why?
| | Infant Mortality | 1 | 2018 | 91 | 0.150 |
Why?
| | Down-Regulation | 1 | 2020 | 594 | 0.150 |
Why?
| | Hand Deformities, Congenital | 1 | 1997 | 8 | 0.150 |
Why?
| | Leadership | 2 | 2022 | 291 | 0.150 |
Why?
| | Torsion Abnormality | 1 | 2017 | 18 | 0.150 |
Why?
| | Syndactyly | 1 | 1997 | 10 | 0.150 |
Why?
| | Pyloric Stenosis, Hypertrophic | 1 | 2017 | 8 | 0.150 |
Why?
| | Circumcision, Male | 1 | 1997 | 14 | 0.150 |
Why?
| | Biocompatible Materials | 2 | 1999 | 372 | 0.150 |
Why?
| | Bone Cements | 1 | 1997 | 35 | 0.140 |
Why?
| | Pancreatectomy | 1 | 2019 | 167 | 0.140 |
Why?
| | Evidence-Based Practice | 4 | 2021 | 185 | 0.140 |
Why?
| | Adenoma | 2 | 2013 | 187 | 0.140 |
Why?
| | Penis | 1 | 1997 | 37 | 0.140 |
Why?
| | Craniosynostoses | 1 | 1997 | 28 | 0.140 |
Why?
| | Titanium | 1 | 1998 | 72 | 0.140 |
Why?
| | Temporal Muscle | 1 | 1997 | 2 | 0.140 |
Why?
| | Skull | 2 | 1996 | 119 | 0.140 |
Why?
| | Prospective Studies | 4 | 2023 | 6195 | 0.140 |
Why?
| | Age Factors | 6 | 2022 | 2885 | 0.140 |
Why?
| | Receptors, Lysosphingolipid | 1 | 2017 | 12 | 0.140 |
Why?
| | Body Composition | 1 | 2021 | 590 | 0.140 |
Why?
| | Information Dissemination | 1 | 2019 | 185 | 0.140 |
Why?
| | Liver Diseases | 1 | 2020 | 254 | 0.140 |
Why?
| | Hospitals, Pediatric | 1 | 2020 | 478 | 0.140 |
Why?
| | Diet | 2 | 2021 | 1080 | 0.140 |
Why?
| | Combined Modality Therapy | 2 | 2017 | 1117 | 0.140 |
Why?
| | Reference Standards | 1 | 2017 | 159 | 0.140 |
Why?
| | Career Choice | 1 | 2019 | 178 | 0.140 |
Why?
| | Child Abuse | 1 | 2022 | 456 | 0.140 |
Why?
| | Bone Screws | 1 | 1998 | 112 | 0.140 |
Why?
| | Pancreatic Neoplasms | 1 | 2023 | 721 | 0.140 |
Why?
| | Therapeutic Irrigation | 1 | 2017 | 65 | 0.140 |
Why?
| | Algorithms | 2 | 2020 | 1469 | 0.140 |
Why?
| | Rhytidoplasty | 1 | 1996 | 5 | 0.140 |
Why?
| | Social Class | 1 | 2018 | 205 | 0.140 |
Why?
| | Cheek | 1 | 1996 | 16 | 0.140 |
Why?
| | Critical Pathways | 1 | 2017 | 76 | 0.140 |
Why?
| | Benchmarking | 1 | 2018 | 161 | 0.140 |
Why?
| | Chickens | 1 | 2017 | 180 | 0.130 |
Why?
| | Risk Assessment | 3 | 2021 | 2958 | 0.130 |
Why?
| | Minimally Invasive Surgical Procedures | 2 | 2019 | 154 | 0.130 |
Why?
| | Escherichia coli | 3 | 2014 | 723 | 0.130 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2017 | 314 | 0.130 |
Why?
| | Mice, Inbred ICR | 2 | 2014 | 108 | 0.130 |
Why?
| | Neoplasms | 2 | 2021 | 2086 | 0.130 |
Why?
| | Wisconsin | 1 | 2016 | 91 | 0.130 |
Why?
| | Workplace | 3 | 2022 | 221 | 0.130 |
Why?
| | Thigh | 2 | 2012 | 53 | 0.130 |
Why?
| | Face | 2 | 1996 | 163 | 0.130 |
Why?
| | Energy Metabolism | 1 | 2021 | 727 | 0.130 |
Why?
| | Feces | 2 | 2021 | 372 | 0.130 |
Why?
| | Hodgkin Disease | 1 | 2017 | 121 | 0.130 |
Why?
| | Case-Control Studies | 1 | 2022 | 3003 | 0.130 |
Why?
| | Professional-Family Relations | 1 | 2017 | 131 | 0.130 |
Why?
| | Sex Factors | 1 | 2021 | 1706 | 0.130 |
Why?
| | Intracranial Pressure | 1 | 1996 | 48 | 0.130 |
Why?
| | Hernias, Diaphragmatic, Congenital | 1 | 2018 | 184 | 0.120 |
Why?
| | Physical Examination | 1 | 2017 | 221 | 0.120 |
Why?
| | Carcinoma, Renal Cell | 1 | 2017 | 168 | 0.120 |
Why?
| | Goldenhar Syndrome | 2 | 1997 | 4 | 0.120 |
Why?
| | Tissue Fixation | 1 | 2015 | 27 | 0.120 |
Why?
| | Extracorporeal Membrane Oxygenation | 1 | 2018 | 241 | 0.120 |
Why?
| | Early Detection of Cancer | 1 | 2018 | 305 | 0.120 |
Why?
| | Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 1995 | 56 | 0.120 |
Why?
| | Intestinal Volvulus | 1 | 2014 | 9 | 0.120 |
Why?
| | Embryonic Development | 1 | 2015 | 117 | 0.110 |
Why?
| | Occipital Bone | 1 | 1994 | 17 | 0.110 |
Why?
| | Radiation Dosage | 1 | 2015 | 133 | 0.110 |
Why?
| | Foramen Magnum | 1 | 1994 | 9 | 0.110 |
Why?
| | Immunoglobulin A | 1 | 2015 | 166 | 0.110 |
Why?
| | Medicaid | 1 | 2018 | 404 | 0.110 |
Why?
| | Evidence-Based Medicine | 1 | 2018 | 662 | 0.110 |
Why?
| | Pregnancy | 5 | 2023 | 5499 | 0.110 |
Why?
| | Attitude of Health Personnel | 2 | 2020 | 970 | 0.110 |
Why?
| | Fascia | 1 | 1993 | 14 | 0.110 |
Why?
| | Muscle, Skeletal | 2 | 2000 | 1468 | 0.110 |
Why?
| | Body Weight | 1 | 2018 | 868 | 0.110 |
Why?
| | Ovarian Neoplasms | 1 | 2018 | 386 | 0.110 |
Why?
| | Adipose Tissue | 2 | 1996 | 545 | 0.110 |
Why?
| | Comorbidity | 1 | 2018 | 1447 | 0.110 |
Why?
| | Graft Survival | 1 | 1996 | 443 | 0.110 |
Why?
| | Registries | 2 | 2021 | 1764 | 0.110 |
Why?
| | Kidney Neoplasms | 1 | 2017 | 324 | 0.110 |
Why?
| | Parathyroid Neoplasms | 1 | 2013 | 13 | 0.110 |
Why?
| | Mice, Inbred BALB C | 2 | 2006 | 1144 | 0.110 |
Why?
| | Mandible | 3 | 2001 | 59 | 0.110 |
Why?
| | Interleukin-17 | 1 | 2014 | 104 | 0.110 |
Why?
| | Peyer's Patches | 1 | 2013 | 7 | 0.110 |
Why?
| | Fluorescent Dyes | 1 | 2015 | 298 | 0.110 |
Why?
| | Patient Transfer | 1 | 2015 | 142 | 0.110 |
Why?
| | Arm | 2 | 1998 | 104 | 0.110 |
Why?
| | Nitric Oxide Synthase Type I | 1 | 2013 | 25 | 0.110 |
Why?
| | Intestine, Small | 1 | 2014 | 121 | 0.100 |
Why?
| | Cervical Vertebrae | 1 | 1994 | 104 | 0.100 |
Why?
| | DNA, Bacterial | 1 | 2014 | 312 | 0.100 |
Why?
| | Quality of Life | 2 | 2021 | 2343 | 0.100 |
Why?
| | Perioperative Care | 1 | 2014 | 126 | 0.100 |
Why?
| | Atrophy | 1 | 2013 | 152 | 0.100 |
Why?
| | Anti-Bacterial Agents | 2 | 2023 | 1471 | 0.100 |
Why?
| | Rabbits | 3 | 1999 | 733 | 0.100 |
Why?
| | Cytogenetic Analysis | 1 | 2012 | 29 | 0.100 |
Why?
| | Parental Leave | 2 | 2022 | 17 | 0.100 |
Why?
| | Liver | 2 | 2023 | 1633 | 0.100 |
Why?
| | Immunologic Factors | 1 | 2014 | 217 | 0.100 |
Why?
| | Disease-Free Survival | 2 | 2023 | 618 | 0.100 |
Why?
| | Mammaplasty | 1 | 1992 | 68 | 0.090 |
Why?
| | Electronic Health Records | 1 | 2018 | 799 | 0.090 |
Why?
| | Time Factors | 5 | 2017 | 6077 | 0.090 |
Why?
| | Sacrum | 1 | 2012 | 62 | 0.090 |
Why?
| | RNA | 1 | 2017 | 806 | 0.090 |
Why?
| | Bone Regeneration | 3 | 2000 | 21 | 0.090 |
Why?
| | Gene Expression Profiling | 1 | 2017 | 1518 | 0.090 |
Why?
| | Shock, Septic | 1 | 1992 | 185 | 0.090 |
Why?
| | Body Mass Index | 1 | 2018 | 1957 | 0.090 |
Why?
| | Nephroma, Mesoblastic | 1 | 2010 | 3 | 0.090 |
Why?
| | Cadaver | 4 | 1997 | 298 | 0.090 |
Why?
| | Homeostasis | 2 | 2023 | 570 | 0.090 |
Why?
| | Decision Making | 1 | 2017 | 760 | 0.090 |
Why?
| | Remission, Spontaneous | 1 | 2010 | 37 | 0.090 |
Why?
| | Inflammation | 3 | 2023 | 2464 | 0.090 |
Why?
| | Anorexia | 1 | 2010 | 18 | 0.090 |
Why?
| | Cranial Sutures | 2 | 2001 | 9 | 0.080 |
Why?
| | Radiography | 3 | 1997 | 803 | 0.080 |
Why?
| | Vomiting | 1 | 2010 | 122 | 0.080 |
Why?
| | Immunity, Innate | 1 | 2014 | 720 | 0.080 |
Why?
| | Hypertension, Pulmonary | 1 | 2019 | 1736 | 0.070 |
Why?
| | Tensile Strength | 2 | 1998 | 88 | 0.070 |
Why?
| | Colforsin | 1 | 2007 | 47 | 0.070 |
Why?
| | Genes, Reporter | 1 | 2008 | 256 | 0.070 |
Why?
| | Isoquinolines | 1 | 2007 | 36 | 0.070 |
Why?
| | Stress, Mechanical | 2 | 2000 | 445 | 0.070 |
Why?
| | Velopharyngeal Insufficiency | 2 | 1997 | 14 | 0.070 |
Why?
| | Cyclic AMP | 1 | 2007 | 225 | 0.070 |
Why?
| | Green Fluorescent Proteins | 1 | 2008 | 370 | 0.070 |
Why?
| | Ovary | 2 | 2018 | 190 | 0.070 |
Why?
| | Cyclic AMP-Dependent Protein Kinases | 1 | 2007 | 130 | 0.070 |
Why?
| | Platelet-Derived Growth Factor | 1 | 2006 | 80 | 0.070 |
Why?
| | Neoplasm Recurrence, Local | 2 | 2023 | 850 | 0.060 |
Why?
| | Prognosis | 3 | 2019 | 3315 | 0.060 |
Why?
| | Consensus | 2 | 2019 | 532 | 0.060 |
Why?
| | Intraoperative Complications | 2 | 2017 | 120 | 0.060 |
Why?
| | Forearm | 3 | 1998 | 112 | 0.060 |
Why?
| | Biomechanical Phenomena | 2 | 1998 | 669 | 0.060 |
Why?
| | Fibroblast Growth Factors | 1 | 2006 | 162 | 0.060 |
Why?
| | Sympathetic Nervous System | 1 | 2006 | 171 | 0.060 |
Why?
| | Central Nervous System Depressants | 1 | 2005 | 80 | 0.060 |
Why?
| | Multiple Organ Failure | 1 | 2005 | 116 | 0.060 |
Why?
| | Skin Aging | 1 | 2004 | 19 | 0.060 |
Why?
| | Middle Aged | 9 | 2021 | 26605 | 0.060 |
Why?
| | Sulfonamides | 1 | 2007 | 444 | 0.060 |
Why?
| | Growth Substances | 1 | 2004 | 138 | 0.060 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2006 | 496 | 0.050 |
Why?
| | Chemokines | 1 | 2005 | 215 | 0.050 |
Why?
| | Parenteral Nutrition, Total | 1 | 2023 | 27 | 0.050 |
Why?
| | Paneth Cells | 1 | 2023 | 17 | 0.050 |
Why?
| | Analysis of Variance | 1 | 2006 | 1218 | 0.050 |
Why?
| | Immune System | 1 | 2005 | 171 | 0.050 |
Why?
| | Delphi Technique | 1 | 2023 | 157 | 0.050 |
Why?
| | Hospitalization | 2 | 2023 | 1762 | 0.050 |
Why?
| | Biological Factors | 1 | 2023 | 35 | 0.050 |
Why?
| | Animals, Genetically Modified | 1 | 2023 | 215 | 0.050 |
Why?
| | Fluid Therapy | 1 | 2023 | 121 | 0.050 |
Why?
| | Syndrome | 2 | 2001 | 330 | 0.050 |
Why?
| | Public Opinion | 1 | 2023 | 59 | 0.050 |
Why?
| | Regeneration | 1 | 2004 | 158 | 0.050 |
Why?
| | Economic Recession | 1 | 2022 | 5 | 0.050 |
Why?
| | Immunohistochemistry | 1 | 2006 | 1624 | 0.050 |
Why?
| | Single Parent | 1 | 2022 | 10 | 0.050 |
Why?
| | Personnel Staffing and Scheduling | 1 | 2022 | 79 | 0.050 |
Why?
| | Echo-Planar Imaging | 1 | 2001 | 14 | 0.050 |
Why?
| | Signal Transduction | 2 | 2020 | 4501 | 0.050 |
Why?
| | Protein Kinase Inhibitors | 1 | 2007 | 784 | 0.050 |
Why?
| | Infertility, Male | 1 | 2022 | 59 | 0.050 |
Why?
| | Evoked Potentials, Motor | 1 | 2001 | 34 | 0.050 |
Why?
| | DNA-Directed RNA Polymerases | 1 | 2021 | 51 | 0.050 |
Why?
| | Anemia, Hemolytic | 1 | 2001 | 18 | 0.050 |
Why?
| | Tissue Transplantation | 1 | 2001 | 11 | 0.050 |
Why?
| | Disseminated Intravascular Coagulation | 1 | 2001 | 29 | 0.050 |
Why?
| | Culture Techniques | 1 | 2001 | 78 | 0.050 |
Why?
| | Swine | 1 | 2023 | 687 | 0.050 |
Why?
| | Elective Surgical Procedures | 1 | 2022 | 150 | 0.050 |
Why?
| | Costs and Cost Analysis | 1 | 2022 | 196 | 0.050 |
Why?
| | Artifacts | 1 | 2001 | 114 | 0.050 |
Why?
| | Embryonic and Fetal Development | 1 | 2001 | 94 | 0.050 |
Why?
| | Food Handling | 1 | 2021 | 49 | 0.050 |
Why?
| | Glasgow Coma Scale | 1 | 2021 | 151 | 0.050 |
Why?
| | Evoked Potentials | 1 | 2001 | 108 | 0.050 |
Why?
| | Thyroid Neoplasms | 1 | 1984 | 271 | 0.050 |
Why?
| | Surgery, Oral | 1 | 2000 | 6 | 0.050 |
Why?
| | Nerve Regeneration | 1 | 2001 | 50 | 0.040 |
Why?
| | Povidone-Iodine | 1 | 2000 | 11 | 0.040 |
Why?
| | Ethanol | 1 | 2005 | 534 | 0.040 |
Why?
| | Enema | 1 | 2020 | 37 | 0.040 |
Why?
| | Mouth | 1 | 2000 | 69 | 0.040 |
Why?
| | Guinea Pigs | 1 | 2000 | 136 | 0.040 |
Why?
| | ROC Curve | 1 | 2021 | 441 | 0.040 |
Why?
| | Patient Admission | 1 | 2021 | 175 | 0.040 |
Why?
| | Cells, Cultured | 1 | 2007 | 3861 | 0.040 |
Why?
| | Methylmethacrylate | 1 | 1999 | 3 | 0.040 |
Why?
| | Dental Implantation, Endosseous | 1 | 1999 | 3 | 0.040 |
Why?
| | Necrosis | 1 | 2000 | 209 | 0.040 |
Why?
| | Culture Media, Conditioned | 1 | 2000 | 103 | 0.040 |
Why?
| | Critical Care | 1 | 2023 | 472 | 0.040 |
Why?
| | Antibiotic Prophylaxis | 1 | 2000 | 95 | 0.040 |
Why?
| | Liver Function Tests | 1 | 2020 | 103 | 0.040 |
Why?
| | Efficiency, Organizational | 1 | 2020 | 126 | 0.040 |
Why?
| | Survival Rate | 1 | 2023 | 1638 | 0.040 |
Why?
| | Genetic Therapy | 1 | 2001 | 256 | 0.040 |
Why?
| | Durapatite | 1 | 1999 | 35 | 0.040 |
Why?
| | Thrombocytopenia | 1 | 2001 | 177 | 0.040 |
Why?
| | Disinfection | 1 | 2000 | 107 | 0.040 |
Why?
| | Sexual and Gender Minorities | 1 | 2022 | 138 | 0.040 |
Why?
| | Cell Count | 1 | 2000 | 303 | 0.040 |
Why?
| | Clinical Decision-Making | 1 | 2021 | 268 | 0.040 |
Why?
| | Organ Size | 1 | 2020 | 434 | 0.040 |
Why?
| | Anticoagulants | 1 | 2023 | 547 | 0.040 |
Why?
| | Extracellular Matrix Proteins | 1 | 2000 | 126 | 0.040 |
Why?
| | Bile Acids and Salts | 1 | 2020 | 171 | 0.040 |
Why?
| | American Medical Association | 1 | 2018 | 17 | 0.040 |
Why?
| | Thoracoscopy | 1 | 2019 | 49 | 0.040 |
Why?
| | Aged, 80 and over | 2 | 2013 | 6306 | 0.040 |
Why?
| | Electromyography | 1 | 2000 | 326 | 0.040 |
Why?
| | Bone Resorption | 1 | 1999 | 73 | 0.040 |
Why?
| | Stainless Steel | 1 | 1998 | 21 | 0.040 |
Why?
| | Host-Pathogen Interactions | 1 | 2021 | 295 | 0.040 |
Why?
| | Miniaturization | 1 | 1998 | 23 | 0.040 |
Why?
| | Aged | 5 | 2013 | 18969 | 0.040 |
Why?
| | Polyglycolic Acid | 1 | 1998 | 43 | 0.040 |
Why?
| | Imaging, Three-Dimensional | 1 | 2001 | 511 | 0.040 |
Why?
| | Pyloromyotomy | 1 | 2017 | 1 | 0.040 |
Why?
| | In Vitro Techniques | 1 | 2000 | 1003 | 0.040 |
Why?
| | Evaluation Studies as Topic | 1 | 1998 | 167 | 0.040 |
Why?
| | Biodegradation, Environmental | 1 | 1998 | 80 | 0.040 |
Why?
| | Atropine | 1 | 2017 | 25 | 0.040 |
Why?
| | Parasympatholytics | 1 | 2017 | 13 | 0.040 |
Why?
| | Ointments | 1 | 1997 | 23 | 0.040 |
Why?
| | Compressive Strength | 1 | 1998 | 70 | 0.040 |
Why?
| | Biomarkers | 2 | 2021 | 3397 | 0.040 |
Why?
| | Research | 1 | 2001 | 389 | 0.040 |
Why?
| | History, 19th Century | 1 | 2017 | 54 | 0.040 |
Why?
| | Emotions | 1 | 2022 | 474 | 0.040 |
Why?
| | Chromosomes, Human, Pair 11 | 1 | 2017 | 57 | 0.040 |
Why?
| | Chromosomes, Human, Pair 6 | 1 | 2017 | 44 | 0.040 |
Why?
| | Transplantation, Autologous | 1 | 1998 | 175 | 0.040 |
Why?
| | Bone Lengthening | 1 | 1997 | 4 | 0.040 |
Why?
| | Petrous Bone | 1 | 1997 | 6 | 0.040 |
Why?
| | Temporomandibular Joint | 1 | 1997 | 9 | 0.040 |
Why?
| | Frontal Bone | 1 | 1997 | 13 | 0.040 |
Why?
| | Intensive Care Units | 1 | 2021 | 614 | 0.040 |
Why?
| | Ear Canal | 1 | 1997 | 14 | 0.040 |
Why?
| | Incidental Findings | 1 | 2017 | 70 | 0.040 |
Why?
| | Mastoid | 1 | 1997 | 15 | 0.030 |
Why?
| | Head and Neck Neoplasms | 1 | 2001 | 427 | 0.030 |
Why?
| | Embolization, Therapeutic | 1 | 2019 | 178 | 0.030 |
Why?
| | Oculomotor Muscles | 1 | 1997 | 38 | 0.030 |
Why?
| | Esophagus | 1 | 2019 | 224 | 0.030 |
Why?
| | Endoscopy | 1 | 2019 | 245 | 0.030 |
Why?
| | Fertility | 1 | 2017 | 128 | 0.030 |
Why?
| | Prostheses and Implants | 1 | 1998 | 135 | 0.030 |
Why?
| | Stem Cells | 1 | 2001 | 541 | 0.030 |
Why?
| | Predictive Value of Tests | 1 | 2021 | 1791 | 0.030 |
Why?
| | Temporal Arteries | 1 | 1997 | 47 | 0.030 |
Why?
| | Osteotomy | 1 | 1998 | 143 | 0.030 |
Why?
| | History, 20th Century | 1 | 2017 | 265 | 0.030 |
Why?
| | Palate, Soft | 1 | 1996 | 10 | 0.030 |
Why?
| | Nephrectomy | 1 | 2017 | 149 | 0.030 |
Why?
| | Adiposity | 1 | 2021 | 458 | 0.030 |
Why?
| | Adenoidectomy | 1 | 1997 | 60 | 0.030 |
Why?
| | Lactic Acid | 1 | 1998 | 272 | 0.030 |
Why?
| | Bone and Bones | 1 | 1999 | 277 | 0.030 |
Why?
| | Otitis Media with Effusion | 1 | 1996 | 21 | 0.030 |
Why?
| | Venous Pressure | 1 | 1996 | 8 | 0.030 |
Why?
| | Postoperative Care | 1 | 2017 | 223 | 0.030 |
Why?
| | Facial Expression | 1 | 1996 | 60 | 0.030 |
Why?
| | Interleukin-6 | 1 | 2020 | 673 | 0.030 |
Why?
| | Ectromelia | 1 | 1995 | 2 | 0.030 |
Why?
| | Stents | 1 | 2019 | 466 | 0.030 |
Why?
| | Sheep | 1 | 1998 | 761 | 0.030 |
Why?
| | Papilledema | 1 | 1996 | 40 | 0.030 |
Why?
| | Matched-Pair Analysis | 1 | 1995 | 33 | 0.030 |
Why?
| | Acute Disease | 1 | 2017 | 907 | 0.030 |
Why?
| | Duodenostomy | 1 | 2014 | 5 | 0.030 |
Why?
| | Intention to Treat Analysis | 1 | 2014 | 69 | 0.030 |
Why?
| | Bone Density | 1 | 1998 | 432 | 0.030 |
Why?
| | Models, Statistical | 1 | 2018 | 595 | 0.030 |
Why?
| | Operative Time | 1 | 2014 | 106 | 0.030 |
Why?
| | Ultrasonography | 1 | 2017 | 635 | 0.030 |
Why?
| | Atlanto-Occipital Joint | 1 | 1994 | 4 | 0.030 |
Why?
| | Odontoid Process | 1 | 1994 | 5 | 0.030 |
Why?
| | Cervical Atlas | 1 | 1994 | 4 | 0.030 |
Why?
| | Cell Line | 1 | 2000 | 2629 | 0.030 |
Why?
| | Mucin-2 | 1 | 2014 | 3 | 0.030 |
Why?
| | Axis, Cervical Vertebra | 1 | 1994 | 7 | 0.030 |
Why?
| | Spinal Cord Compression | 1 | 1994 | 17 | 0.030 |
Why?
| | Polymers | 1 | 1998 | 448 | 0.030 |
Why?
| | Blood Loss, Surgical | 1 | 2014 | 82 | 0.030 |
Why?
| | Phospholipases A2, Secretory | 1 | 2014 | 21 | 0.030 |
Why?
| | Logistic Models | 1 | 2018 | 1829 | 0.030 |
Why?
| | Technetium Tc 99m Sestamibi | 1 | 2013 | 12 | 0.030 |
Why?
| | Skin | 1 | 1998 | 653 | 0.030 |
Why?
| | Reference Values | 1 | 1995 | 739 | 0.030 |
Why?
| | Interleukin-13 | 1 | 2014 | 121 | 0.030 |
Why?
| | Radionuclide Imaging | 1 | 2013 | 115 | 0.030 |
Why?
| | Interleukin-4 | 1 | 2014 | 204 | 0.030 |
Why?
| | Reproducibility of Results | 2 | 1997 | 2764 | 0.030 |
Why?
| | Fractures, Bone | 1 | 1998 | 367 | 0.030 |
Why?
| | Cohort Studies | 1 | 2022 | 4883 | 0.030 |
Why?
| | Skin Ulcer | 1 | 1992 | 13 | 0.020 |
Why?
| | Disease Susceptibility | 1 | 2014 | 316 | 0.020 |
Why?
| | Mice, 129 Strain | 1 | 2012 | 77 | 0.020 |
Why?
| | Scalp | 1 | 1992 | 29 | 0.020 |
Why?
| | Muscles | 1 | 1992 | 320 | 0.020 |
Why?
| | Tendons | 1 | 1992 | 118 | 0.020 |
Why?
| | Nerve Fibers | 1 | 2012 | 86 | 0.020 |
Why?
| | Blotting, Western | 1 | 2014 | 1143 | 0.020 |
Why?
| | Gene Expression Regulation | 1 | 2020 | 2322 | 0.020 |
Why?
| | Fibrosarcoma | 1 | 2010 | 20 | 0.020 |
Why?
| | Databases, Factual | 1 | 2013 | 1125 | 0.020 |
Why?
| | Antineoplastic Agents | 1 | 2017 | 1875 | 0.020 |
Why?
| | Multiple Endocrine Neoplasia | 1 | 1984 | 6 | 0.010 |
Why?
| | Arteries | 2 | 1994 | 246 | 0.010 |
Why?
| | Culture Media | 1 | 2001 | 155 | 0.010 |
Why?
| | Organ Culture Techniques | 1 | 2001 | 140 | 0.010 |
Why?
| | Colony Count, Microbial | 1 | 2000 | 111 | 0.010 |
Why?
| | Sodium Chloride | 1 | 2000 | 133 | 0.010 |
Why?
| | Frostbite | 1 | 1998 | 6 | 0.010 |
Why?
| | Facial Injuries | 1 | 1998 | 16 | 0.010 |
Why?
| | Finger Injuries | 1 | 1998 | 21 | 0.010 |
Why?
| | Facial Asymmetry | 1 | 1997 | 5 | 0.010 |
Why?
| | Mandibulofacial Dysostosis | 1 | 1997 | 5 | 0.010 |
Why?
| | Shoulder | 1 | 1998 | 84 | 0.010 |
Why?
| | Micrognathism | 1 | 1997 | 10 | 0.010 |
Why?
| | Radiographic Image Enhancement | 1 | 1997 | 52 | 0.010 |
Why?
| | Ligation | 1 | 1994 | 75 | 0.010 |
Why?
| | Mandibular Neoplasms | 1 | 1994 | 22 | 0.010 |
Why?
| | Anastomosis, Surgical | 1 | 1994 | 135 | 0.010 |
Why?
| | Mouth Neoplasms | 1 | 1994 | 70 | 0.010 |
Why?
| | Water | 1 | 1997 | 394 | 0.010 |
Why?
| | Emergencies | 1 | 1994 | 143 | 0.010 |
Why?
| | Image Processing, Computer-Assisted | 1 | 1997 | 684 | 0.010 |
Why?
| | Wound Infection | 1 | 1992 | 30 | 0.010 |
Why?
| | Abdomen | 1 | 1992 | 99 | 0.010 |
Why?
| | Wounds, Penetrating | 1 | 1992 | 68 | 0.010 |
Why?
| | Craniocerebral Trauma | 1 | 1992 | 133 | 0.010 |
Why?
| | Carcinoma, Squamous Cell | 1 | 1994 | 577 | 0.010 |
Why?
|
|
Gosain's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|